In this research, zeolite A was synthesized from waste porcelain and CdS nano-particles were doped in zeolite framework by a precipitation after an ion exchanging process. All raw and modified samples were characterized by FT-IR, XRD and SEM methods. Primary experiments showed that the good efficiency of loaded nano CdS onto the zeolite A for photodecomposition of dimethyldisulfide (DMDS) under...

Chang’e-5 (CE-5) successfully landed on the young basalts area in northeastern Oceanus Procellarum 1 December 2020. Recent studies CE-5 landing have shown that lack of gas-related volcanic morphology indicates volatile elements captured interior Moon within late-stage magma is relatively low. Typical lunar features include dark mantle deposits, pits, irregular mare patches and so on. Based orbi...

• Multiple sclerosis (MS), a chronic, recurrent infl ammatory disease, is characterized by infl ammatory attacks on central nervous system myelin. Patients with MS experience symptoms such as blurred vision, walking and coordination problems, bladder or bowel dysfunction, numbness, and cognitive impairment.1 • Approximately 85% of patients with MS have relapsing–remitting MS (RRMS), which is ch...

Background: Progressive brain atrophy is a major feature of multiple sclerosis (MS) pathology and is actually considered a major determinant of the progressive accumulation of physical and cognitive disability in MS patients. Although brain atrophy may have different pathological substrates, several lines of evidence suggest that in disease modifying drug (DMD)-treated MS patients, the higher i...

OBJECTIVE To compare the cancer risk of cladribine and other disease-modifying drugs (DMDs) in trials of people with relapsing multiple sclerosis (pwRMS). METHODS Meta-analysis of phase III trials of licensed DMDs for pwRMS and a phase III trial of cladribine (CLARITY). Cancer rates were compared using Fisher exact test. RESULTS Eleven trials were included. Investigated treatments included ...

The mechanisms leading to disability and the long-term efficacy and safety of disease modifying drugs (DMDs) in multiple sclerosis (MS) are unclear. We aimed at building a prospective cohort of MS patients with standardized collection of demographic, clinical, MRI data and body fluids that can be used to develop prognostic indicators and biomarkers of disease evolution and therapeutic response....

Dimethyl disulfide (DMDS) and N-methylacetamide are two first choice model systems that represent the disulfide bridge bonding and the peptide bonding in proteins. These molecules are therefore suitable for investigation of the mechanisms involved when proteins fragment under electron capture dissociation (ECD). The dissociative recombination cross sections for both protonated DMDS and protonat...

OBJECTIVE The treatment of multiple sclerosis (MS) with disease-modifying-drugs (DMDs) is evolving and new drugs are reaching the market. Efficacy and safety aspects of the drugs are crucial, but the patients' satisfaction with the treatment must be taken into consideration. METHODS Individual interview with patients with MS regarding their satisfaction and points of view on the treatment wit...